PharmaDiagnostics Raises $3.7 Million
PharmaDiagnostics NV, a Brussels-based developer of screening technology has raised EUR 2.5 million ($3.7 million) in a second round of funding from Capital-E and an undisclosed group of investors.
13 October 2009•3 mins read
